Correspondence 0001437749-24-035778 from Autonomix Medical, Inc. (AMIX)
Autonomix Medical, Inc.
Date: Nov. 19, 2024 · CIK: 0001617867 · Accession: 0001437749-24-035778
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282940
Letter
amix20241119_corresp.htm
Autonomix Medical, Inc.
21 Waterway Avenue, Suite 300
The Woodlands, TX 77380
November 19, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Washington, DC 20549
Re:
Autonomix Medical, Inc. Registration Statement on Form S-1 File No. 333-282940
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Autonomix Medical, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 5:30 P.M. (Eastern Time) on November 21, 2024, or as soon thereafter as possible on such date.
Very truly yours,
Autonomix Medical, Inc.
Show Raw Text
CORRESP 1 filename1.htm amix20241119_corresp.htm Autonomix Medical, Inc. 21 Waterway Avenue, Suite 300 The Woodlands, TX 77380 November 19, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance Washington, DC 20549 Re: Autonomix Medical, Inc. Registration Statement on Form S-1 File No. 333-282940 Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, Autonomix Medical, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 5:30 P.M. (Eastern Time) on November 21, 2024, or as soon thereafter as possible on such date. Very truly yours, Autonomix Medical, Inc. By: /s/ Trent Smith Name: Trent Smith Title: Chief Financial Officer